Resolution of early stage diabetic nephropathy in an obese diabetic patient after gastric bypass

Perez G.; Devaud, N; Escalona A.; Downey P.

Abstract

Epidemiological studies have proven that obesity is a significant risk factor for type 2 diabetes. Long-term progression of diabetes leads to various microvascular complications, of which diabetic nephropathy has become of increasing importance, and is the main cause of end-stage renal failure in occidental countries. Microalbuminuria is the first marker of incipient diabetic nephropathy, an early stage glomerulopathy which can progress to renal failure and which historically has been treated with angiotensin converting enzyme (ACE) inhibitors or angiotensin II receptor antagonists. We report a severely obese diabetic patient on treatment for diabetic nephropathy with ACE-inhibitors and poor results, which resolved after Roux-en-Y gastric bypass. © FD-Communications Inc.

Más información

Título según WOS: Resolution of early stage diabetic nephropathy in an obese diabetic patient after gastric bypass
Título según SCOPUS: Resolution of early stage diabetic nephropathy in an obese diabetic patient after gastric bypass
Título de la Revista: OBESITY SURGERY
Volumen: 16
Número: 10
Editorial: Springer
Fecha de publicación: 2006
Página de inicio: 1388
Página final: 1391
Idioma: English
URL: http://link.springer.com/10.1381/096089206778663733
DOI:

10.1381/096089206778663733

Notas: ISI, SCOPUS